Competitive pathway analysis implicated the biological processes of neurogenesis and synaptic regulation, as well as the gene targets of two pharmacologic agents: cinnarizine, a T -
type calcium channel blocker, and LY97241, a potassium channel inhibitor.
Not exact matches
A large observational study found that use of short - acting
calcium channel blockers (CCBs) for hypertension is associated with increased incidence of pancreatic cancer among postmenopausal women, when compared with the use of other
types of antihypertensive medication and never - use of such agents.
Whilst this work is still at an early stage, it shows the potential of using
calcium channel blockers to target immune system activity to combat this
type of disease.
There are several
types (classes) of blood - pressure lowering drugs that are commonly used including Beta
blockers, ACE inhibitors and
Calcium channel blockers.
Some drugs that have that ability are beta
blockers like Atenolol (Tenormin) and propranolol (Inderal),
calcium channel blockers like diltiazem (Cardizem), digoxin (Lanoxin, Cardoxin), pimobendan (Vetmedin), various narcotics as well as insecticide poisoning (organophosphate
type)
They reported that the thiazide -
type diuretic chlorthalidone outshone three other treatments — a
calcium channel blocker, an ACE inhibitor and an alpha - receptor
blocker — in most areas.